ORKA stock

Oruka Therapeutics, Inc. (ORKA) financials · $4.27B cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Oruka Therapeutics, Inc. (ORKA) $4.27B cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$122.1MN/A
Net Income-$105.4M-$83.7M
EPS (Diluted)N/A-$3.87
Cached annual balance sheet
LineFY2025FY2024
Total Assets$488.6M$396.0M
Current Assets$343.9M$376.9M
Cash & Equivalents$46.9M$61.6M
PP&E$288.0K$162.0K
Total Liabilities$16.7M$13.8M
Current Liabilities$15.4M$13.0M
Shareholders' Equity$471.9M$382.2M
Retained Earnings-$189.2M-$83.7M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$88.2M-$57.8M
CapEx$209.0K$189.0K
Investing Cash Flow-$96.7M-$330.1M
Financing Cash Flow$170.3M$449.5M
Free Cash Flow-$88.4M-$58.0M
These statements as JSON? API free 100/day

FAQ

What is ORKA P/E and revenue?

Oruka Therapeutics, Inc. (ORKA) $4.27B cap.

What is ORKA revenue?

ORKA income-statement cache has no revenue figure yet.

Is ORKA profitable?

Oruka Therapeutics, Inc. last cached net income is -$105.4M (FY2025).

What are ORKA total assets?

Oruka Therapeutics, Inc. last cached total assets are $488.6M (FY2025).

What is ORKA free cash flow?

Oruka Therapeutics, Inc. last cached free cash flow is -$88.4M (FY2025).

Not investment advice. Cached statements, not a live tape.